Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia

3 Pogledi
administrator
administrator
08/04/23

In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.

  • Kategorija

Prikaži više

0 Komentari Poredaj po

Nema komentara

Komentari na Facebooku

Sljedeći